___

• Albertini MC, Radogna F, Accorsi A, Uguccioni F, Paternoster L, Cerella C, De Nicola M, D’Alessio M, Bergamaschi A, Magrini A et al. (2006). Intracellular pro-oxidant activity of melatonin deprives U937 cells of reduced glutathione without affecting glutathione peroxidase activity. Ann NY Acad Sci 1091: 10–16.
• Ambrose JA, Barua RS (2004). The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43: 1731–1737.
• Anton-Tay F, Martinez I, Tovar R, Benitez-King G (1998). Modulation of the subcellular distribution of calmodulin by melatonin in MDCK cells. J Pineal Res 24: 35–42.
• Barceló A, Barbé F (2005). Oxidative stress and sleep apnea-hypopnea syndrome. Arch Bronconeumol 41: 393–399 (in Spanish).
• Bejarano I, Espino J, Barriga C, Reiter RJ, Pariente JA, Rodriguez AB (2011). Pro-oxidant effect of melatonin in tumour leucocytes: relation with its cytotoxic and pro-apoptotic effects. Basic Clin Pharmacol Toxicol 108: 14–20.
• Bergstrom T, Ersson C, Bergman J, Moller L (2012). Vitamins at physiological levels cause oxidation to the DNA nucleoside deoxyguanosine and to DNA-alone or in synergism with metals. Mutagenesis 27: 511–517.
• Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE (2014). Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 94: 329–354.
• Bjelakovic G, Nikolova D, Gluud C (2013). Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm? PLoS One 8: e74558.
• Bouayed J, Bohn T (2010). Exogenous antioxidants - Double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev 3: 228–237.
• Büyükavcı M, Özdemir O, Buck S, Stout M, Ravindranath Y, Savaşan S (2006). Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect. Fundam Clin Pharmacol 20: 73–79.
• Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ (2005). A review of the multiple actions of melatonin on the immune system. Endocrine 27: 189–200.
• Chandra J, Samali A, Orrenius S (2000). Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29: 323– 333.
• Clapp-Lilly KL, Smith MA, Perry G, Harris PL, Zhu X, Duffy LK (2001). Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer’s disease. Neuroreport 12: 1277–1280.
• Cristofanon S, Uguccioni F, Cerella C, Radogna F, Dicato M, Ghibelli L, Diederich M (2009). Intracellular prooxidant activity of melatonin induces a survival pathway involving NF-κB activation. Ann NY Acad Sci 1171: 472–478.
• Cross AR, Jones OT (1991). Enzymic mechanisms of superoxide production. Biochim Biophys Acta 1057: 281–298.
• Cui P, Yu M, Peng X, Dong L, Yang Z (2012). Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression. J Pineal Res 52: 236–243.
• Dreher D, Junod AF (1996). Role of oxygen free radicals in cancer development. Eur J Cancer 32A: 30–38.
• Dubocovich ML, Markowska M (2005). Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27: 101–110.
• Ekmekçioğlu C (2006). Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 60: 97–108.
• Ekmekçioğlu C (2014). Expression and putative functions of melatonin receptors in malignant cells and tissues. Wien Med Wochenschr 164: 472–478.
• Elmahallawy EK, Jimenez-Aranda A, Martinez AS, Rodriguez- Granger J, Navarro-Alarcon M, Gutierrez-Fernandez J, Agil A (2014). Activity of melatonin against Leishmania infantum promastigotes by mitochondrial dependent pathway. Chem Biol Interact 220: 84–93.
• Ernster L (1993). Lipid peroxidation in biological membranes: mechanisms and implications. In: Yagi K, editor. Active Oxygens, Lipid Peroxides, and Antioxidants. Boca Raton, FL, USA: CRC Press, pp. 1–38.
• Esparza JL, Gomez M, Rosa Nogues M, Paternain JL, Mallol J, Domingo JL (2005). Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum of aluminum-exposed rats. J Pineal Res 39: 129–136.
• Finkel T, Holbrook NJ (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408: 239–247.
• Fischer TW, Kleszczynski K, Hardkop LH, Kruse N, Zillikens D (2013). Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2’-deoxyguanosine) in ex vivo human skin. J Pineal Res 54: 303–312.
• Frei B, Forte TM, Ames BN, Cross CE (1991). Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem J 277 (Pt 1): 133–138.
• Fridovich I (1986). Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 58: 61–97.
• Fu J, Zhao SD, Liu HJ, Yuan QH, Liu SM, Zhang YM, Ling EA, Hao AJ (2011). Melatonin promotes proliferation and differentiation of neural stem cells subjected to hypoxia in vitro. J Pineal Res 51: 104–112.
• Galano A, Tan DX, Reiter RJ (2013). On the free radical scavenging activities of melatonin’s metabolites, AFMK and AMK. J Pineal Res 54: 245–257.
• Galano A, Tan DX, Reiter RJ (2014). Cyclic 3-hydroxymelatonin, a key metabolite enhancing the peroxyl radical scavenging activity of melatonin. RSC Advances 4: 5220–5227.
• Garcia-Santos G, Antolin I, Herrera F, Martin V, Rodriguez-Blanco J, del Pilar Carrera M, Rodriguez C (2006). Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 41: 130–135.
• Girish KS, Paul M, Thushara RM, Hemshekhar M, Shanmuga Sundaram M, Rangappa KS, Kemparaju K (2013). Melatonin elevates apoptosis in human platelets via ROS mediated mitochondrial damage. Biochem Biophys Res Commun 438: 198–204.
• Gomez M, Esparza JL, Nogues MR, Giralt M, Cabre M, Domingo JL (2005). Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic Biol Med 38: 104–111.
• Gonzalez A, del Castillo-Vaquero A, Miro-Moran A, Tapia JA, Salido GM (2011). Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology. J Pineal Res 50: 250–260.
• Halliwell B (2006). Oxidative stress and neurodegeneration: where are now? J Neurochem 97: 1634-1658.
• Hardeland R, Fuhrberg B (1996). Ubiquitous melatonin: Presence and effects in unicells, plants and animals. Trends Comp Biochem Physiol 2: 25–45.
• Hardeland R, Reiter RJ, Poeggeler B, Tan DX (1993). The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 17: 347–357.
• Jones DP (2008). Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295: C849–868.
• Kojima T, Mochizuki C, Mitaka T, Mochizuki Y (1997). Effects of melatonin on proliferation, oxidative stress and Cx32 gap junction protein expression in primary cultures of adult rat hepatocytes. Cell Struct Funct 22: 347–356.
• Kotler M, Rodriguez C, Sainz RM, Antolin I, Menendez-Pelaez A (1998). Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 24: 83–89.
• Leon J, Escames G, Rodriguez MI, Lopez LC, Tapias V, Entrena A, Camacho E, Carrion MD, Gallo MA, Espinosa A et al. (2006). Inhibition of neuronal nitric oxide synthase activity by N1- acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem 98: 2023–2033.
• Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W (1958). Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 80: 2587.
• Lopez LC, Escames G, Ortiz F, Ros E, Acuna-Castroviejo D (2006). Melatonin restores the mitochondrial production of ATP in septic mice. Neuro Endocrinol Lett 27: 623–630.
• Lu T, Finkel T (2008). Free radicals and senescence. Exp Cell Res 314: 1918–1922.
• Luchetti F, Canonico B, Betti M, Arcangeletti M, Pilolli F, Piroddi M, Canesi L, Papa S, Galli F (2010). Melatonin signaling and cell protection function. FASEB J 24: 3603–3624.
• Martin M, Macias M, Escames G, Reiter RJ, Agapito MT, Ortiz GG, Acuna-Castroviejo D (2000). Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 28: 242–248.
• Martin M, Macias M, Leon J, Escames G, Khaldy H, Acuna- Castroviejo D (2002). Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 34: 348–357.
• Mauriz JL, Collado PS, Veneroso C, Reiter RJ, Gonzalez-Gallego J (2013). A review of the molecular aspects of melatonin’s anti- inflammatory actions: recent insights and new perspectives. J Pineal Res 54: 1–14.
• Medina-Navarro R, Duran-Reyes G, Hicks JJ (1999). Pro-oxidating properties of melatonin in the in vitro interaction with the singlet oxygen. Endocr Res 25: 263–280.
• Nakayama T, Church DF, Pryor WA (1989). Quantitative analysis of the hydrogen peroxide formed in aqueous cigarette tar extracts. Free Radic Biol Med 7: 9–15.
• Ordoñez R, Carbajo-Pescador S, Prieto-Dominguez N, García- Palomo A, González-Gallego J, Mauriz JL (2014). Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells. J Pineal Res 56: 20–30.
• Osseni RA, Rat P, Bogdan A, Warnet JM, Touitou Y (2000). Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 68: 387–399.
• Packer MA, Porteous CM, Murphy MP (1996). Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem Mol Biol Int 40: 527–534.
• Petrosillo G, Di Venosa N, Pistolese M, Casanova G, Tiravanti E, Colantuono G, Federici A, Paradies G, Ruggiero FM (2006). Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: role of cardiolipin. FASEB J 20: 269–276.
• Pieri C, Moroni F, Marra M, Marcheselli F, Recchioni R (1995). Melatonin is an efficient antioxidant. Arch Gerontol Geriatr
• Radogna F, Diederich M, Ghibelli L (2010). Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 80: 1844–1852.
• Radogna F, Paternoster L, De Nicola M, Cerella C, Ammendola S, Bedini A, Tarzia G, Aquilano K, Ciriolo M, Ghibelli L (2009a). Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes. Toxicol Appl Pharmacol 239: 37–45.
• Radogna F, Sestili P, Martinelli C, Paolillo M, Paternoster L, Albertini MC, Accorsi A, Gualandi G, Ghibelli L (2009b). Lipoxygenase- mediated pro-radical effect of melatonin via stimulation of arachidonic acid metabolism. Toxicol Appl Pharmacol 238: 170–177.
• Reiter RJ, Calvo JR, Karbownik M, Qi W, Tan DX (2000). Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 917: 376–386.
• Reiter RJ, Guerrero JM, Escames G, Pappolla MA, Acuna-Castroviejo D (1997). Prophylactic actions of melatonin in oxidative neurotoxicity. Ann NY Acad Sci 825: 70–78.
• Reiter RJ, Tan DX, Burkhardt S (2002). Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev 123: 1007–1019.
• Reiter RJ, Tan DX, Kim SJ, Qi W (1998). Melatonin as a pharmacological agent against oxidative damage to lipids and DNA. P West Pharmacol Soc 41: 229–236.
• Reiter RJ, Tan DX, Rosales-Corral S, Manchester LC (2013). The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem 13: 373–384.
• Reiter RJ, Tan DX, Terron MP, Flores LJ, Czarnocki Z (2007). Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 54: 1–9.
• Reppert SM, Weaver DR, Ebisawa T (1994). Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13: 1177–1185.
• Ressmeyer AR, Mayo JC, Zelosko V, Sainz RM, Tan DX, Poeggeler B, Antolin I, Zsizsik BK, Reiter RJ, Hardeland R (2003). Antioxidant properties of the melatonin metabolite N1-acetyl- 5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep 8: 205–213.
• Rezaie A, Parker RD, Abdollahi M (2007). Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 52: 2015–2021.
• Richter C, Park JW, Ames BN (1988). Normal oxidative damage to mitochondrial and nuclear DNA is extensive. P Natl Acad Sci USA 85: 6465–6467.
• Rodriguez C, Martin V, Herrera F, Garcia-Santos G, Rodriguez- Blanco J, Casado-Zapico S, Sanchez-Sanchez AM, Suarez S, Puente-Moncada N, Anitua MJ et al. (2013). Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells. Int J Mol Sci 14: 6597–6613.
• Rubio S, Estevez F, Cabrera J, Reiter RJ, Loro J, Quintana J (2007). Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells. J Pineal Res 42: 131–138.
• Santanam N, Sanchez R, Hendler S, Parthasarathy S (1997). Aqueous extracts of cigarette smoke promote the oxidation of low density lipoprotein by peroxidases. FEBS Lett 414: 549–551.
• Sarti P, Magnifico MC, Altieri F, Mastronicola D, Arese M (2013). New evidence for cross talk between melatonin and mitochondria mediated by a circadian-compatible interaction with nitric oxide. Int J Mol Sci 14: 11259–11276.
• Sinha K, Das J, Pal PB, Sil PC (2013). Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 87: 1157–1180.
• Stadtman ER (1992). Protein oxidation and aging. Science 257: 1220–1224.
• Stankov B, Reiter RJ (1990). Melatonin receptors: current status, facts, and hypotheses. Life Sci 46: 971–982.
• Tan DX, Hardeland R, Manchester LC, Galano A, Reiter RJ (2014). Cyclic-3-hydroxymelatonin (C3HOM), a potent antioxidant, scavenges free radicals and suppresses oxidative reactions. Curr Med Chem 21: 1557–1565.
• Tan DX, Manchester LC, Burkhardt S, Sainz RM, Mayo JC, Kohen R, Shohami E, Huo YS, Hardeland R, Reiter RJ (2001). N1- Acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 15: 2294–2296.
• Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ (2007). One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42: 28–42.
• Tan DX, Manchester LC, Terron MP, Flores LJ, Tamura H, Reiter RJ (2007). Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance. J Pineal Res 43: 317–320.
• Trubiani O, Recchioni R, Moroni F, Pizzicannella J, Caputi S, Di Primio R (2005). Melatonin provokes cell death in human B-lymphoma cells by mitochondrial-dependent apoptotic pathway activation. J Pineal Res 39: 425–431.
• Valls V, Castelluccio C, Fato R, Genova ML, Bovina C, Saez G, Marchetti M, Parenti Castelli G, Lenaz G (1994). Protective effect of exogenous coenzyme Q against damage by adriamycin in perfused rat liver. Biochem Mol Biol Int 33: 633–642.
• Wiesenberg I, Missbach M, Carlberg C (1998). The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 12: 143–150.
• Wolfler A, Caluba HC, Abuja PM, Dohr G, Schauenstein K, Liebmann PM (2001). Prooxidant activity of melatonin promotes fas- induced cell death in human leukemic Jurkat cells. FEBS Lett
• Zhang H, Zhang HM, Wu LP, Tan DX, Kamat A, Li YQ, Katz MS, Abboud HE, Reiter RJ, Zhang BX (2011). Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db/db mice. J Pineal Res 51: 338–344.
• Zhang HM, Zhang Y (2014). Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 57: 131–146.
• Zhang HM, Zhang Y, Zhang BX (2011). The role of mitochondrial complex III in melatonin-induced ROS production in cultured mesangial cells. J Pineal Res 50: 78–82.